Welcome to our dedicated page for Alberton Acquisition news (Ticker: ALAC), a resource for investors and traders seeking the latest updates and insights on Alberton Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Alberton Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Alberton Acquisition's position in the market.
On October 9, 2020, Alberton Acquisition Corporation (NASDAQ: ALAC) announced a proposal to extend the deadline for completing its initial business combination from October 26, 2020, to April 26, 2021. If shareholders approve this Extension, ALAC will provide an additional cash contribution of $0.05 per share monthly into the trust account for shares not redeemed. As of September 18, 2020, the redemption amount per share stood at approximately $10.73, which could increase to approximately $11.03 if the full extension is utilized.
FAQ
What is the market cap of Alberton Acquisition (ALAC)?
